BGM Group Ltd. (NASDAQ:BGM) Short Interest Down 13.0% in February

BGM Group Ltd. (NASDAQ:BGM) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 65,241 shares, a decline of 13.0% from the February 12th total of 74,988 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 24,801 shares, the short-interest ratio is currently 2.6 days. Based on an average daily volume of 24,801 shares, the short-interest ratio is currently 2.6 days. Currently, 0.2% of the shares of the company are short sold.

BGM Group Price Performance

Shares of BGM stock opened at $0.90 on Wednesday. BGM Group has a 12-month low of $0.90 and a 12-month high of $17.17. The firm has a 50-day moving average price of $2.09 and a 200 day moving average price of $5.87.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Mariner LLC bought a new stake in BGM Group during the 3rd quarter worth approximately $267,000. Marshall Wace LLP acquired a new position in BGM Group in the second quarter worth $218,000. Finally, Geode Capital Management LLC acquired a new position in BGM Group in the second quarter worth $412,000.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of BGM Group in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About BGM Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.